Seroatlas · Human Serome Atlas

VDAC1

Non-selective voltage-gated ion channel VDAC1

Also known as: MGC111064, PORIN, VDAC1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P21796
Gene
VDAC1
Ensembl
ENSG00000213585
Chromosome
5
Canonical length
283 aa
Protein class
Plasma proteins, Predicted intracellular proteins
Quaternary structure
Homotrimer

OverviewNCBI Gene

This gene encodes a voltage-dependent anion channel protein that is a major component of the outer mitochondrial membrane. The encoded protein facilitates the exchange of metabolites and ions across the outer mitochondrial membrane and may regulate mitochondrial functions. This protein also forms channels in the plasma membrane and may be involved in transmembrane electron transport. Alternate splicing results in multiple transcript variants. Multiple pseudogenes of this gene are found on chromosomes 1, 2 3, 6, 9, 12, X and Y.[provided by RefSeq, Sep 2010]

Canonical amino-acid sequenceUniProt

283 residues, UniProt reviewed canonical sequence.

>P21796|VDAC1
     1  MAVPPTYADL GKSARDVFTK GYGFGLIKLD LKTKSENGLE FTSSGSANTE TTKVTGSLET
    61  KYRWTEYGLT FTEKWNTDNT LGTEITVEDQ LARGLKLTFD SSFSPNTGKK NAKIKTGYKR
   121  EHINLGCDMD FDIAGPSIRG ALVLGYEGWL AGYQMNFETA KSRVTQSNFA VGYKTDEFQL
   181  HTNVNDGTEF GGSIYQKVNK KLETAVNLAW TAGNSNTRFG IAAKYQIDPD ACFSAKVNNS
   241  SLIGLGYTQT LKPGIKLTLS ALLDGKNVNA GGHKLGLGLE FQA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against VDAC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
19
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
980 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 980 nTPM
  • tongue: 758 nTPM
  • heart muscle: 378 nTPM
  • retina: 293 nTPM
  • duodenum: 250 nTPM
  • choroid plexus: 226 nTPM

Single-cell type

  • parietal cells: 1,169 nCPM
  • esophageal apical cells: 934 nCPM
  • esophageal suprabasal cells: 516 nCPM
  • migrating cytotrophoblasts: 513 nCPM
  • extravillous trophoblasts: 508 nCPM
  • esophageal basal cells: 447 nCPM

Immune cell

  • myeloid DC: 141 nTPM
  • intermediate monocyte: 118 nTPM
  • non-classical monocyte: 106 nTPM
  • NK-cell: 88 nTPM
  • classical monocyte: 83 nTPM
  • T-reg: 75 nTPM

Brain region

  • choroid plexus: 229 nTPM
  • cerebral cortex: 185 nTPM
  • hypothalamus: 172 nTPM
  • pons: 165 nTPM
  • thalamus: 159 nTPM
  • medulla oblongata: 153 nTPM

ReferencesPubMed · IEDB

Publications for VDAC1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.31
gnomAD pLI
0.97
gnomAD missense Z
1.33
DepMap mean gene effect
-0.76
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of VDAC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads VDAC1 as an antibody target. Whether an autoantibody or antibody against VDAC1 could matter depends on whether native VDAC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

VDAC1 is annotated at the cell surface, where native VDAC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label VDAC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/VDAC1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...